Vivanza Biosciences Limited (BOM:530057)
India
· Delayed Price · Currency is INR 2.020
+0.090 (4.66%)
At close: Mar 10, 2026
Vivanza Biosciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 81 | 80 | 272 | 752 | 755 | 522 | Upgrade
|
| Market Cap Growth | -16.87% | -70.69% | -63.88% | -0.34% | 44.45% | 896.95% | Upgrade
|
| Enterprise Value | 176 | 140 | 322 | 807 | 784 | 556 | Upgrade
|
| Last Close Price | 2.02 | 1.99 | 6.79 | 18.80 | 18.86 | 13.06 | Upgrade
|
| PE Ratio | - | - | 49.63 | 125.69 | 226.61 | 693.43 | Upgrade
|
| PS Ratio | 0.07 | 1.07 | 0.97 | 4.14 | 6.74 | 5.26 | Upgrade
|
| PB Ratio | 1.75 | 2.01 | 5.86 | 18.38 | 21.61 | 16.53 | Upgrade
|
| P/TBV Ratio | 2.71 | 3.42 | 9.05 | 30.62 | 40.63 | 34.28 | Upgrade
|
| P/FCF Ratio | - | - | 13.54 | - | 30.59 | - | Upgrade
|
| P/OCF Ratio | - | - | 13.29 | - | 30.59 | - | Upgrade
|
| EV/Sales Ratio | 0.16 | 1.88 | 1.16 | 4.44 | 7.00 | 5.60 | Upgrade
|
| EV/EBITDA Ratio | 101.61 | - | 28.78 | 70.90 | 91.48 | 193.18 | Upgrade
|
| EV/EBIT Ratio | 111.53 | - | 29.10 | 71.06 | 92.28 | 200.01 | Upgrade
|
| EV/FCF Ratio | - | - | 16.07 | - | 31.78 | - | Upgrade
|
| Debt / Equity Ratio | 2.20 | 2.18 | 1.12 | 1.96 | 1.58 | 0.11 | Upgrade
|
| Debt / EBITDA Ratio | 58.46 | - | 4.61 | 7.03 | 6.43 | 1.24 | Upgrade
|
| Debt / FCF Ratio | - | - | 2.58 | - | 2.23 | - | Upgrade
|
| Net Debt / Equity Ratio | 2.07 | 2.15 | 1.07 | 1.91 | 1.56 | 1.09 | Upgrade
|
| Net Debt / EBITDA Ratio | 54.99 | -29.22 | 4.44 | 6.88 | 6.36 | 11.98 | Upgrade
|
| Net Debt / FCF Ratio | - | -3.39 | 2.48 | -8.28 | 2.21 | -1.24 | Upgrade
|
| Asset Turnover | - | 0.42 | 1.33 | 0.96 | 0.93 | 0.96 | Upgrade
|
| Inventory Turnover | - | 3.20 | 11.58 | 6.73 | 6.26 | 11.29 | Upgrade
|
| Quick Ratio | - | 0.90 | 0.96 | 0.75 | 0.83 | 0.60 | Upgrade
|
| Current Ratio | - | 1.35 | 1.29 | 1.15 | 1.31 | 0.95 | Upgrade
|
| Return on Equity (ROE) | - | -15.67% | 12.54% | 15.78% | 10.01% | 2.41% | Upgrade
|
| Return on Assets (ROA) | - | -1.06% | 3.30% | 3.73% | 4.42% | 1.67% | Upgrade
|
| Return on Invested Capital (ROIC) | 1.12% | -2.76% | 8.11% | 9.09% | 10.91% | 2.64% | Upgrade
|
| Return on Capital Employed (ROCE) | - | -4.20% | 15.10% | 20.50% | 14.00% | 8.80% | Upgrade
|
| Earnings Yield | -1.89% | -8.47% | 2.02% | 0.80% | 0.44% | 0.14% | Upgrade
|
| FCF Yield | - | -31.49% | 7.39% | -1.26% | 3.27% | -5.33% | Upgrade
|
| Buyback Yield / Dilution | 1.23% | -2.32% | 2.27% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.